• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Covance

Covance

Covance Inc CVD 3 Star

Last Price$106.72Day Change (%)-0.59%
Open Price$107.35Day Change ($)-0.63
Day Range106.62–107.3552-Week Range73.57–107.35

As of Fri 01/23/2015 04:46 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Global CRO Market 2015-2019 with Covance , Parexel International, PRA Health Sciences & Quintiles Translational Dominating

    Research and Markets: Global CRO Market 2015-2019 with Covance , Parexel International, PRA Health Sciences & Quintiles Translational Dominating

  2. Research and Markets: CRO Quality Benchmarking - Phase IV Service Providers (6th edition)

    Research and Markets: CRO Quality Benchmarking - Phase IV Service Providers (6th edition)

  3. ContraVir Pharmaceuticals adds Renu Gupta, M.D., to Scientific Advisory Board

    ContraVir Pharmaceuticals adds Renu Gupta, M.D., to Scientific Advisory Board

  4. Late-Stage Businesses Drive Narrow Moats for CROs

    The top contract research organizations have opportunities to gain share in a rapidly growing industry.

  5. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.